Researchers compared longitudinal clinical outcomes in patients undergoing TAVR with balloon expandable versus self-expanding valves in patients who received either therapy from 2014 to 2020.
Researchers compared longitudinal clinical outcomes in patients undergoing TAVR with balloon expandable versus self-expanding valves in patients who received either therapy from 2014 to 2020.
“This research is the first of its kind to look at such a large cohort of AS patients over a four-year span. Findings serve as a stark reminder of the poor prognosis associated with untreated AS irrespective of severity, suggesting patients...
“This research is the first of its kind to look at such a large cohort of AS patients over a four-year span. Findings serve as a stark reminder of the poor prognosis associated with untreated AS irrespective of severity, suggesting patients...
The ShortCut leaflet splitting procedure can be done in anywhere from five to 10 minutes, says Dr. Susheel Kodali, and patients typically remain stable during the procedure.
The ShortCut leaflet splitting procedure can be done in anywhere from five to 10 minutes, says Dr. Susheel Kodali, and patients typically remain stable during the procedure.
The multicenter, randomized WATCH-TAVR trial set out to investigate the safety of implantation of the WATCHMAN 2.5 device at the time of TAVR and to compare the efficacy of WATCHMAN LAAO with contemporary medical therapy in this population of...
The multicenter, randomized WATCH-TAVR trial set out to investigate the safety of implantation of the WATCHMAN 2.5 device at the time of TAVR and to compare the efficacy of WATCHMAN LAAO with contemporary medical therapy in this population of...
"The five-year follow-up findings from the PARTNER 3 trial reaffirm the clinical outcome benefits and bioprosthetic valve durability of SAPIEN 3 TAVR as a meaningful alternative to surgical therapy for low-risk severe, symptomatic AS...
"The five-year follow-up findings from the PARTNER 3 trial reaffirm the clinical outcome benefits and bioprosthetic valve durability of SAPIEN 3 TAVR as a meaningful alternative to surgical therapy for low-risk severe, symptomatic AS...
The trial met prespecified non-inferiority criteria for its primary safety endpoint and primary efficacy endpoint. Outcomes were presented by Dr. Vinod Thourani (Piedmont Heart Institute, Atlanta, GA).
The trial met prespecified non-inferiority criteria for its primary safety endpoint and primary efficacy endpoint. Outcomes were presented by Dr. Vinod Thourani (Piedmont Heart Institute, Atlanta, GA).
“TAVR is an amazing technology," says Benjamin Z. Galper, MD, MPH. "But for some reason, TAVR is not being disseminated in the population as widely as it should be, given that we have so many structural heart programs across the country. Why...
“TAVR is an amazing technology," says Benjamin Z. Galper, MD, MPH. "But for some reason, TAVR is not being disseminated in the population as widely as it should be, given that we have so many structural heart programs across the country. Why...
Since the approval of TAVR in low-risk surgical patients, there is an ongoing need for evidence to better understand the intermediate and longer-term durability of TAVR devices of different designs.
Since the approval of TAVR in low-risk surgical patients, there is an ongoing need for evidence to better understand the intermediate and longer-term durability of TAVR devices of different designs.
"SAFE-TAVI Clinical Study: SavvyWire Efficacy and Safety in TAVI Procedures" will be presented on Wed, Oct 25, at 10:09am PST, at Moderated Abstracts Station 2 – Emerging Clinical Science & Research, Hall A, Exhibition Level, Moscone South
"SAFE-TAVI Clinical Study: SavvyWire Efficacy and Safety in TAVI Procedures" will be presented on Wed, Oct 25, at 10:09am PST, at Moderated Abstracts Station 2 – Emerging Clinical Science & Research, Hall A, Exhibition Level, Moscone South
“Our conclusion,” said Prof. Tony Walton, “was that routine protamine administration should be considered in all patients undergoing TAVI, unless a recent coronary intervention has been performed.”
“Our conclusion,” said Prof. Tony Walton, “was that routine protamine administration should be considered in all patients undergoing TAVI, unless a recent coronary intervention has been performed.”
With several hotly anticipated late-breaking clinical trial results centering around transcatheter aortic valve replacement (TAVR), the 2023 TCT meeting, held October 23-26 in San Francisco, California, promises attendees a deep dive into the...
With several hotly anticipated late-breaking clinical trial results centering around transcatheter aortic valve replacement (TAVR), the 2023 TCT meeting, held October 23-26 in San Francisco, California, promises attendees a deep dive into the...
Cath Lab Digest's TCT 2023 Newsroom will provide a special focus on TAVR. The Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Symposium will take place October 23-26 in San Francisco, California.
Cath Lab Digest's TCT 2023 Newsroom will provide a special focus on TAVR. The Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Symposium will take place October 23-26 in San Francisco, California.
Cath Lab Digest's TCT 2023...
09/20/2023
Cath Lab Digest
Find More at the TVT Structural Heart Summit Newsroom
